Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2008, Pages 105-111

  Cleary, Jeffrey C ^a   Karmazyn, Yauel ^a   Mogayzel Jr , Peter J ^a   Laube, Beth L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

2 adrenergic receptor agonists; Aerosols; Mucociliary clearance

Indexed keywords

ISOTOPE; LEVALBUTEROL; PLACEBO; SALBUTAMOL; TECHNETIUM 99M;

ADULT; AEROSOL; ARTICLE; CHRONICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; LONG TERM CARE; MALE; MUCOCILIARY CLEARANCE; NEBULIZER; NERVOUSNESS; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCINTILLATION CAMERA; SIDE EFFECT; TREATMENT DURATION; TREMOR;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG; MALE; MUCOCILIARY CLEARANCE; NEBULIZERS AND VAPORIZERS;

EID: 38049051018     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.01.002     Document Type: Article

References (28)

1. Cloutier M.M., Guernsey L., Mattes P., and Koeppen B. Duramycin enhances chloride secretion in airway epithelium. Am J Physiol 259 (1990) C450-C454
2. Boucher R.C. Drug therapy in the 1990s. What can we expect for cystic fibrosis?. Drugs 43 (1992) 431-439
3. Afzelius B.A. Role of cilia in human health. Cell Motil Cytoskeleton 32 (1995) 95-97
4. Mortensen J., Groth S., Lange P., and Hermansen F. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler. Thorax 46 (1991) 817-823
5. Mortensen J., Lange P., Nyboe J., and Groth S. Lung mucociliary clearance. Eur J Nucl Med 21 (1994) 953-961
6. Lafortuna C.L., and Fazio F. Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis. Respiration 45 (1984) 111-123
7. Foster W.M., Bergofsky E.H., Bohning D.E., Lippmann M., and Albert R.E. Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J Appl Physiol 41 (1976) 146-152
8. Foster W.M., Langenback E., and Bergofsky E.H. Measurement of tracheal and bronchial mucus velocities in man: relation to lung clearance. J Appl Physiol 48 (1980) 965-971
9. Perry R.J., and Smaldone G.C. Effect of bronochodilators on mucociliary clearance in normal adults. J Aerosol Med 3 (1990) 187-196
10. Yeates D.B., Aspin N., Levinson H., Jones M.T., and Bryan A.C. Mucociliary transport rates in man. J Appl Physiol 39 (1975) 487-494
11. Olivieri D., Marsico S.A., Illiano A., and Del Donno M. In vivo measurement of drug effect on mucociliary transport. Eur J Respir Dis 64 Suppl 128 (1983) 551-553
12. Konietzko N., Klopfer M., Adam W.E., and Matthys H. Die mokociliare klarfunktion der lunge unter β-adrenerger stimulation. Pneumologie 152 (1975) 203-208
13. Pavia D., Bateman J.R.M., Sheahan N.F., and Clarke S.W. Clearance of lung secretions in patients with chronic-bronchitis-effect of terbutaline and ipratropium bromide aerosols. Eur J Respir Dis 61 (1980) 245-253
14. Sadoul P., Puchelle E., Zahm J.M., Jacquot J., Aug F., and Polu J.M. Effect of terbutaline on mucociliary transport and sputum properties in chronic-bronchitis. Chest 80 (1981) 885-889
15. Matthys H., Daikeler G., Krauss B., and Vastag E. Action of tulobuterol and fenoterol on the mucociliary clearance. Respiration 51 (1987) 105-112
16. Broadley K.J. β-adrenoceptor responses of the airways: for better or worse?. Eur J Pharmacol 533 (2006) 15-27
17. Frohock J.I., Wijkstrom-Frei C., and Salathe M. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells. J Appl Physiol 92 (2002) 2396-2402
18. Boulton D.W., and Fawcett P.J. The pharmacokinetics of levalbutamol: what are the clinical implications?. Clin Pharmacokinet 40 (2001) 23-40
19. Laube B.L., Karmazyn Y.J., Orens J.B., and Mogayzel Jr. P.J. Albuterol improves impaired mucociliary clearance following lung transplantation. JHLT 26 (2007) 138-144
20. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet (2001) 1191-1194
21. Nelson H.S., Bensch G., Pleskow W.W., DiSantostefano R., DeGraw S., Reasner D.S., et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 102 (1998) 943-952
22. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
23. Laube B.L., Edwards A.M., Dalby R.N., Creticos P.S., and Norman P.S. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 101 (1998) 475-483
24. Laube B.L., Norman P.S., and Adams III G.K. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. J Allergy Clin Immunol 89 (1992) 510-518
25. Laube B.L., Auci R.M., Shields D.E., Christiansen D.H., Lucas M.K., Fuchs H.J., et al. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 153 (1996) 752-760
26. Laube B.L., Karmazyn Y., Clark A.R., and Newhouse M. Targeted aerosol delivery in healthy human lungs. In: Dalby R.N., Byron P.R., and Farr S.T. (Eds). Respiratory drug delivery IX (2004), Serentek Press, Inc., Raleigh, NC 525-527
27. 2 agonist. Respir Med 99 (2005) 145-151
28. Hayes M.J., Qing F., Rhodes C.G., Rahman S.U., Ind P.W., Sriskandan S., et al. In vivo quantification of human pulmonary beta-adrenoceptors: Effect of beta-agonist therapy. Am J Respir Crit Care Med 154 (1996) 1277-1283